- Home
- FMST vs LVTX Comparison
FMST vs LVTX Comparison
Compare FMST & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMST
- LVTX
- Stock Information
- Founded
- FMST 2005
- LVTX 2016
- Country
- FMST Canada
- LVTX Netherlands
- Employees
- FMST N/A
- LVTX N/A
- Industry
- FMST Other Metals and Minerals
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- FMST Basic Materials
- LVTX Health Care
- Exchange
- FMST Nasdaq
- LVTX Nasdaq
- Market Cap
- FMST 38.2M
- LVTX 40.8M
- IPO Year
- FMST N/A
- LVTX 2021
- Fundamental
- Price
- FMST $3.48
- LVTX $1.60
- Analyst Decision
- FMST
- LVTX Hold
- Analyst Count
- FMST 0
- LVTX 4
- Target Price
- FMST N/A
- LVTX $1.58
- AVG Volume (30 Days)
- FMST 513.5K
- LVTX 439.0K
- Earning Date
- FMST 11-21-2025
- LVTX 08-13-2025
- Dividend Yield
- FMST N/A
- LVTX N/A
- EPS Growth
- FMST N/A
- LVTX N/A
- EPS
- FMST N/A
- LVTX N/A
- Revenue
- FMST N/A
- LVTX $4,990,000.00
- Revenue This Year
- FMST N/A
- LVTX N/A
- Revenue Next Year
- FMST N/A
- LVTX N/A
- P/E Ratio
- FMST N/A
- LVTX N/A
- Revenue Growth
- FMST N/A
- LVTX N/A
- 52 Week Low
- FMST $0.55
- LVTX $0.85
- 52 Week High
- FMST $5.74
- LVTX $2.09
- Technical
- Relative Strength Index (RSI)
- FMST 59.53
- LVTX 58.95
- Support Level
- FMST $2.94
- LVTX $1.53
- Resistance Level
- FMST $3.52
- LVTX $1.64
- Average True Range (ATR)
- FMST 0.24
- LVTX 0.05
- MACD
- FMST 0.03
- LVTX 0.00
- Stochastic Oscillator
- FMST 86.57
- LVTX 85.42
About FMST Foremost Lithium Resource & Technology Ltd. Common stock
Foremost Clean Energy Ltd is an emerging North American uranium and lithium exploration company. Its uranium portfolio consists of projects at different stages of exploration from grassroots, to those with historical exploration and drill-ready targets. It also maintains a secondary portfolio of lithium projects at different stages of development spanning 50,000-plus acres across Manitoba and Quebec. Geographically it covers Canada and United states.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.